Adcon L

Drug Profile

Adcon L

Alternative Names: Adcon-L; Adocon-L; GL-402; GT-402

Latest Information Update: 15 Oct 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wright Medical Group
  • Developer Wright Medical Group; Wright Medical Japan; Wright Medical Technology
  • Class Organic chemicals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Epidural fibrosis; Post-surgical adhesions

Most Recent Events

  • 14 Mar 2003 Gliatech's Adcon® Gel technology has been purchased by Wright Medical Group Inc.
  • 01 Nov 2002 The US FDA is resuming scientific review of Gliatech's applications
  • 26 Sep 2002 Gliatech is auctioning its Adcon® assets
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top